Testing a new blood pressure drug
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must not have high blood pressure caused by another condition (like kidney disease or a hormone problem).
- You must not have a condition called orthostatic hypotension (dizziness or fainting when you stand up).
- You must not need to take other blood pressure drugs during the study.
- You must not have type 1 diabetes or poorly controlled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pill that combines two blood pressure medicines to see if it can lower blood pressure more effectively in people with moderate to severe high blood pressure. If you have high blood pressure that is not well controlled, this trial might help you find a new treatment option.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
This trial tests a new medicine called SPC1001 Low to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). If you are between 19 and 75 years old and have mild to moderate high blood pressure, this study might be an option.
This trial tests whether a combination of two blood pressure drugs (sacubitril/valsartan) is better than one drug alone (valsartan) at improving heart function in people with high blood pressure. It may help reduce strain on the heart's upper chambers.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
This trial compares two blood-pressure and heart-failure medicines: sacubitril/valsartan versus ramipril, to see which improves heart pumping and heart structure over time. It’s aimed at people with ischemic (blocked-artery) heart failure with mid-range ejection fraction and ongoing symptoms.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.